128 related articles for article (PubMed ID: 38295597)
1. Estimating the risk and benefit of radiation therapy in (y)pN1 stage breast cancer patients: A Bayesian network model incorporating expert knowledge (KROG 22-13).
Jang BS; Chun SJ; Choi HS; Chang JH; Shin KH;
Comput Methods Programs Biomed; 2024 Mar; 245():108049. PubMed ID: 38295597
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Overall Disease Burden in (y)pN1 Breast Cancer Using Knowledge-Based Machine Learning Model.
Chun SJ; Jang BS; Choi HS; Chang JH; Shin KH; Division For Breast Cancer Korean Radiation Oncology Group
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672575
[TBL] [Abstract][Full Text] [Related]
3. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
4. Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418).
Yoo GS; Park W; Yu JI; Choi DH; Kim YJ; Shin KH; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2019 Jul; 51(3):1041-1051. PubMed ID: 30384580
[TBL] [Abstract][Full Text] [Related]
5. Does addition of postmastectomy radiotherapy improve outcome of patients with pT1-2, N0 triple negative breast cancer as compared to breast conservation therapy?
Raghavan RK; Ibrahim S; Jagathnath Krishna KM; Mathew BS
J Cancer Res Ther; 2019; 15(5):1031-1034. PubMed ID: 31603106
[TBL] [Abstract][Full Text] [Related]
6. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
7. Postmastectomy radiation therapy for triple negative, node-negative breast cancer.
Haque W; Verma V; Farach A; Brian Butler E; Teh BS
Radiother Oncol; 2019 Mar; 132():48-54. PubMed ID: 30825969
[TBL] [Abstract][Full Text] [Related]
8. Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.
Kim K; Park HJ; Shin KH; Kim JH; Choi DH; Park W; Ahn SD; Kim SS; Kim DY; Kim TH; Kim JH; Kim J
Cancer Res Treat; 2018 Oct; 50(4):1316-1323. PubMed ID: 29334604
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.
Speers C; Pierce LJ
JAMA Oncol; 2016 Aug; 2(8):1075-82. PubMed ID: 27243924
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study.
Bhoo-Pathy N; Verkooijen HM; Wong FY; Pignol JP; Kwong A; Tan EY; Aishah Taib N; Nei WL; Ho GF; Tan B; Chan P; Lee SC; Hartman M; Yip CH; Dent R
Int J Cancer; 2015 Nov; 137(10):2504-12. PubMed ID: 26018878
[TBL] [Abstract][Full Text] [Related]
12. Radiation Therapy Versus No Radiation Therapy to the Neo-breast Following Skin-Sparing Mastectomy and Immediate Autologous Free Flap Reconstruction for Breast Cancer: Patient-Reported and Surgical Outcomes at 1 Year-A Mastectomy Reconstruction Outcomes Consortium (MROC) Substudy.
Cooke AL; Diaz-Abele J; Hayakawa T; Buchel E; Dalke K; Lambert P
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):165-172. PubMed ID: 28816143
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
[TBL] [Abstract][Full Text] [Related]
15. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
[TBL] [Abstract][Full Text] [Related]
16. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
[TBL] [Abstract][Full Text] [Related]
17. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Xia LY; Xu WY; Zhao Y
PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer.
Algan O; Zhao YD; Herman T
Clin Breast Cancer; 2016 Aug; 16(4):e99-e106. PubMed ID: 27292180
[TBL] [Abstract][Full Text] [Related]
19. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
20. Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Ahmed KA; Liveringhouse CL; Mills MN; Figura NB; Grass GD; Washington IR; Harris EE; Czerniecki BJ; Blumencranz PW; Eschrich SA; Scott JG; Diaz R; Torres-Roca JF
EBioMedicine; 2019 Sep; 47():163-169. PubMed ID: 31416721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]